Healthcare Blogs

  Cell Viability Assays Market Highlights The imperative factor driving the global cell viability assays market growth is the growing prevalence of chronic ailments and infectious diseases. Other important factors aiding the market growth include growing availability of funds for cell-based research, increasing focus on developing cell-based therapeutics, and the rising need of cell-based assays in research and development (R&D) activities. Cell Viability Assays Market Overview and analysis by product, cell type, application, end-user, forecast till 2030. Cell viability assays is a type of technique that is used for determining viable cells in the culture. Market Research Future (MRFR) has published a research report about the global cell viability assays market is anticipated to reach USD 3.83 billion by 2030 at 8.50% CAGR during the forecast period 2022-2030. Market Segmentation The global cell viability assays market segmentation has segmented the market into applicatio

  Veterinary CBD Market Analysis    The veterinary CBD market is predicted to reach USD 410.41 Million at a 53.4% CAGR between 2022 - 2030, according to the recent Market Research Future (MRFR) report. Pet/veterinary CBD treatment, simply put, is the treatment offered to pets for treating various diseases, including seizures, cancer, anxiety, and more. It is generally derived from two sources- hemp and marijuana.    Different factors are propelling the growth of the veterinary CBD market such as fewer side effects, burgeoning demand by pet owners for organic healthcare products, different benefits of using pet CBD such as to treat osteoarthritis, reduce tiredness and fatigue, balance mood swings, maintain mental health, and manage pet pain, seizures, and anxiety. Besides, a rise in the number of household pets, an increase in the willingness to invest in pet healthcare, no requirement for customization, new and untapped market, and low implementation cost are also adding marke

  Pain Relief Medication Market Highlights Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain. The global pain relief medication market growth is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market. Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in July 2018, AbbVie received approval for Orilissa (elagolix) from the US Food and Drug Administration (FDA) for the management

  Blood Flow Measurement Devices Market Highlights Blood flow measurement devices are measurement devices that are used by the physician to understand the nature of the blood flow such as the amount of blood supplied to various vital organs and abnormal changes in the blood flow velocity, which can cause malformation of vessels. The Blood Flow Measurement Devices Market is projected to reach USD 359.24 Million by 2030 at 8.8% CAGR during the forecast period 2022-2030. The growth of the market is due to the increasing cardiovascular disorders, increasing obesity rates, and growing demand for minimally invasive procedures. Entering the untapped market is an opportunity for the blood flow measurement devices market. Similarly, the high cost of the devices and lack of skilled professionals can hamper the growth of the market. Segmentation The global blood flow measurement devices market is segmented based on application, product, and end-user. By product, the market is segmen

Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, several biosimilar insulin markets are expected to launch in the coming years. According to MRFR analysis, the Insulin Biosimilars Market was valued at USD 2311 Million in 2019 and is expected to register a CAGR of 5.40% during the forecast period of 2020 to 2027. The USFDA approved new insulin glargine Basilar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA’

  Aesthetics Market Overview The global aesthetics market, during the forecast period 2022 to 2030, will register growth at a CAGR of 13.92%. The market for aesthetics is set to reach USD 320 billion by 2030. As per analysts, the global market is anticipated to witness growth owing to the factors such as non-invasive and minimally invasive aesthetic procedures as well as the demand for non-invasive and minimally invasive aesthetic procedures. However, the aesthetics market will face challenges and restraints due to risks associated with aesthetic procedures and the growing demand for advanced devices during the forecast period 2022 to 2030. Emergence of technically innovative devices in the market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the aesthetics market to understand potential threats and challenges the market companies could face. Although the aesthetics market is poised to grow at a fast pace across

  Immunoassay Analyzers Market Scenario Immunoassay analyzers is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzers market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fuelled the market’s growth. On the other hand, high cost of instruments and poor reimbursement policies may restrain this growth during the forecasted period.  The Immunoassay Analyzers Market is anticipated to reach USD 1,588.16 Million by 2030 at 5.40% CAGR during the forecast period 2022-2030. Segmentat